ABG Innovation Capital Partners III GP

Latest statistics and disclosures from ABG Innovation Capital Partners III GP's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are CSTL, AADI, SYBX, and represent 100.00% of ABG Innovation Capital Partners III GP's stock portfolio.
  • Reduced shares in these 1 stock: CSTL.
  • ABG Innovation Capital Partners III GP was a net seller of stock by $-69k.
  • ABG Innovation Capital Partners III GP has $832k in assets under management (AUM), dropping by -7.55%.
  • Central Index Key (CIK): 0001845297

Tip: Access up to 7 years of quarterly data

Positions held by ABG Innovation Capital Partners III GP consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for ABG Innovation Capital Partners III GP

ABG Innovation Capital Partners III GP holds 3 positions in its portfolio as reported in the March 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Castle Biosciences (CSTL) 89.5 $745k -8% 34k 22.15
 View chart
Aadi Bioscience (AADI) 7.5 $62k 27k 2.34
 View chart
Synlogic Com New (SYBX) 3.0 $25k 14k 1.79
 View chart

Past Filings by ABG Innovation Capital Partners III GP

SEC 13F filings are viewable for ABG Innovation Capital Partners III GP going back to 2020